In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii
- PMID: 3105452
- PMCID: PMC174724
- DOI: 10.1128/AAC.31.2.346
In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii
Abstract
We investigated the activity of roxithromycin (RU 965) and gamma interferon alone and in combination in a murine model of toxoplasmic encephalitis. Roxithromycin at a dosage of 35 or 50 mg per mouse per day decreased mortality. Gamma interferon alone significantly prolonged time to death. When combined, the two agents were remarkably synergistic.
Similar articles
-
Activity of roxithromycin against Toxoplasma gondii in murine models.J Antimicrob Chemother. 1987 Nov;20 Suppl B:69-74. doi: 10.1093/jac/20.suppl_b.69. J Antimicrob Chemother. 1987. PMID: 3429388
-
Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.Antimicrob Agents Chemother. 1986 Aug;30(2):323-4. doi: 10.1128/AAC.30.2.323. Antimicrob Agents Chemother. 1986. PMID: 3767344 Free PMC article.
-
In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice.Eur J Clin Microbiol. 1987 Aug;6(4):479-81. doi: 10.1007/BF02013115. Eur J Clin Microbiol. 1987. PMID: 3665901
-
[New pathogens and mode of action of azithromycin: Toxoplasma gondii].Pathol Biol (Paris). 1995 Jun;43(6):561-4. Pathol Biol (Paris). 1995. PMID: 8539083 Review. French.
-
AIDS commentary. Toxoplasmic encephalitis.J Infect Dis. 1988 Jan;157(1):1-6. doi: 10.1093/infdis/157.1.1. J Infect Dis. 1988. PMID: 3121758 Review. No abstract available.
Cited by
-
Current recommendations and future prospects in the treatment of toxoplasmosis.Drugs. 1989 Dec;38(6):973-87. doi: 10.2165/00003495-198938060-00008. Drugs. 1989. PMID: 2693048 Review.
-
Synergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in mice.Eur J Clin Microbiol Infect Dis. 1992 Jan;11(1):71-3. doi: 10.1007/BF01971278. Eur J Clin Microbiol Infect Dis. 1992. PMID: 1314177
-
Activity of gamma interferon in combination with pyrimethamine or clindamycin in treatment of murine toxoplasmosis.Eur J Clin Microbiol Infect Dis. 1990 May;9(5):358-60. doi: 10.1007/BF01973746. Eur J Clin Microbiol Infect Dis. 1990. PMID: 2115442
-
New directions for macrolide antibiotics: structural modifications and in vitro activity.Antimicrob Agents Chemother. 1989 Sep;33(9):1413-8. doi: 10.1128/AAC.33.9.1413. Antimicrob Agents Chemother. 1989. PMID: 2684004 Free PMC article. Review. No abstract available.
-
Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay.Antimicrob Agents Chemother. 1991 May;35(5):903-9. doi: 10.1128/AAC.35.5.903. Antimicrob Agents Chemother. 1991. PMID: 1854172 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical